Atazanavir

Jacobson IM, Everson GT, Gordon SC, Kauffman R, McNair L, Muir A, McHutchison JG (2007) Interim analysis results from a phase 2 study of telaprevir with peginterferon alfa-2A and ribavirin in treatment-naive subjects with hepatitis C. AASLD 58th Annual Meet, Abstract 177 Johnson M (2006) Response to Atazanavir/ritonavir versus lopinavir/ritonavir equivalent or different efficacy profiles by HUl. AIDS 20 1987... [Pg.105]

Zidovudine Didanosine Stavudine Lamivudine Abacavir Tenofovir Emtricitabine Nevirapine Efavirenz TMC125 Saquinavir Indinavir Lopinavir Fosamprenavir Atazanavir Tipranavir Darunavir Raltegravir Elvitegravir Enluvirtide Maraviroc Vicriviroc Bevirimat... [Pg.335]

Tenofovir + Emtricitabine Zidovudine + Lamivudine Abacavir + Lamivudine Efavirenz or Nevirapine Lopinavir/r or Atazanavir/r or Eosamprenavir/r or Saquinavir/r... [Pg.336]

Atazanavir or fosamprenavir or nelfinavir or saquinavir/ ritonavir, and zidovudine or stavudine or tenofovir or abacavir or didanosine, and lamivudine or emtricitabine... [Pg.1259]

Drugs that should not be combined due to overlapping toxi-cities include amprenavir oral solution plus ritonavir oral solution, atazanavir plus indinavir (due to enhanced hyperbilirubinemia), and any combination of didanosine, stavudine, and zalcitabine. Emtricitabine and lamivudine should not be combined because of their similar chemical structures, and antagonism can result when lamivudine is combined with zalcitabine, or stavudine is combined with zidovudine. [Pg.1259]

TC, lamivudine ABC, abacavir APV, amprenavir AST, aspartate aminotransferase ALT, alanine aminotransferase ATV, atazanavir CBC, complete blood cell count D/C, discontinue ddl, didano-sine d4T, stavudine EFV, efavirenz FTC, emtricitabine P1BV, hepatitis B virus F1CV, hepatitis C vims HIV, human immunodeficiency virus IDV, indinavir IV, intravenous LFT, liver function tests LPV/r, lopinavir + ritonavir NNRTI, nonnucleoside reverse transcriptase inhibitor NRTI, nucleoside reverse transcriptase inhibitor NVP, nevirapine PI, protease inhibitor PT, prothrombin time T.bili, total bilirubin TDF, tenofovir disoproxiI fumarate TPV, tipranavir ULN, upper limit of normal ZDV, zidovudine. [Pg.1271]

Your patient begins treatment with atazanavir 300 mg PO once daily, ritonavir 100 mg PO once daily, tenofovir 300 mg PO once daily, and lamivudine 300 mg PO once daily. He initially does well on this regimen, but after about 3 months, he has difficulty taking his medications at the same time every day due to his busy schedule. Because of his job, he relocated to Alabama, and has not been seen in your clinic for 2 years. He returns today to see you in clinic and complains of feeling tired, but otherwise no specific complaints. [Pg.1274]

Lopinavir/ritonavir or atazanavir/ritonavir and (zidovudine or fosamprenavir/ritonavir or tenofovir) and (lamivudine or emtricitabine). [Pg.1275]

Protease inhibitors (amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir) Rifampin... [Pg.350]

Lopinavir/ritonavir (twice daily) (coformulated) (All) Alternatives Atazanavir (Bll)... [Pg.452]

HIV protease inhibitors atazanavir, HepG2 Divergence in class, dislipidemia [25]... [Pg.423]

Drugs that may affect indinavir include didanosine, aldesleukin, anticonvulsants, atazanavir, nelfinavir, nevirapine, omeprazole, rifapentine, ritonavir, clarithromycin, azole antifungals, rifamycins, delavirdine, efavirenz, St. John s wort. [Pg.1812]

Cross-resistance Cross-resistance among Pis has been observed. Tipranavir had less than 4-fold decreased susceptibility against 90% (94 of 105) of HIV-1 isolates resistant to amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir, or saquinavir. Tipranavir-resistant viruses that emerged in vitro had decreased susceptibility to the Pis amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, and ritonavir but remained sensitive to saquinavir. [Pg.1814]

Therapy-naive patients 400 mg (two 200 mg capsules) once daily taken with food. Therapy-experienced patients Atazanavir 300 mg (two 150 mg capsules) once daily... [Pg.1826]

Atazanavir without ritonavir is not recommended for treatment-experienced patients with prior virologic failure. [Pg.1827]

Didanosine-buffered formulations - Give atazanavir (with food) 2 hours before or 1 hour after didanosine. [Pg.1827]

Efavirenz - In treatment-naive patients who receive efavirenz and atazanavir, the recommended dose is atazanavir 300 mg with ritonavir 100 mg and efavirenz 600 mg (all once daily). [Pg.1827]

See also in sourсe #XX -- [ Pg.424 ]

See also in sourсe #XX -- [ Pg.186 ]

See also in sourсe #XX -- [ Pg.50 ]

See also in sourсe #XX -- [ Pg.81 ]

See also in sourсe #XX -- [ Pg.407 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.81 ]

See also in sourсe #XX -- [ Pg.192 ]

See also in sourсe #XX -- [ Pg.530 , Pg.537 ]

See also in sourсe #XX -- [ Pg.31 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.325 ]

See also in sourсe #XX -- [ Pg.7 ]

See also in sourсe #XX -- [ Pg.207 ]

See also in sourсe #XX -- [ Pg.243 ]

See also in sourсe #XX -- [ Pg.213 , Pg.215 ]

See also in sourсe #XX -- [ Pg.92 ]

See also in sourсe #XX -- [ Pg.81 ]

See also in sourсe #XX -- [ Pg.1219 , Pg.1223 ]

See also in sourсe #XX -- [ Pg.319 ]

See also in sourсe #XX -- [ Pg.117 , Pg.121 , Pg.123 ]

See also in sourсe #XX -- [ Pg.402 ]

See also in sourсe #XX -- [ Pg.433 ]

See also in sourсe #XX -- [ Pg.112 , Pg.113 , Pg.115 ]

See also in sourсe #XX -- [ Pg.269 ]

See also in sourсe #XX -- [ Pg.368 , Pg.377 ]

See also in sourсe #XX -- [ Pg.320 , Pg.321 ]

See also in sourсe #XX -- [ Pg.204 ]

See also in sourсe #XX -- [ Pg.483 , Pg.484 , Pg.485 , Pg.487 ]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...